Objectives: Nursing home (NH) residents with dementia is exposed to high rates of
psychotropic prescriptions. Our objectives were to:(1) pool the prevalence estimates of …

Introduction Cholinergic dysfunction, demonstrated in the late 1970s and early 1980s, led to
the introduction of acetylcholinesterase inhibitors (AChEIs) in 1993 (Tacrine) to enhance …

Importance Community-dwelling older adults with dementia have a high prevalence of
psychotropic and opioid use. In these patients, central nervous system (CNS)–active …

Background Fatigue is a common symptom in neurodegenerative diseases and is
associated with decreased cognitive performances. A full knowledge of the causes and …

Purpose Because of the common and increasing use of antipsychotics in older adults, we
aim to summarize the current knowledge on the causes of antipsychotic-related risk of falls …

Objective To investigate longitudinal changes in symptomatic and preventive medication
use among community-dwelling people with and without Alzheimer's disease (AD) 5 years …

Objectives To investigate whether acetylcholinesterase inhibitor (AChEI) use prevents or
delays subsequent initiation of psychotropic medications in people with Alzheimer's disease …

Abstract Background and Objectives Antipsychotics and cognitive enhancers are often used
to treat psychosis and behavioral disturbances in individuals with dementia; however, these …

Polypharmacy in Treatment of Behavioral Issues in Dementia—Use of Atypical
Antipsychotics - Clinics in Geriatric Medicine Skip to Main Content Skip to Main Menu …

Background Psychotropic drugs are frequently prescribed to people with dementia in
nursing homes although severe adverse events and side effects are common. Less is known …